IE
PLRX icon

Israel Englander’s Pliant Therapeutics PLRX Stock Holding History

Israel Englander’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$638K Sell
559,447
-621,071
-53% -$756K ﹤0.01% 4610
2026
Q1 		$1.49M Buy
1,180,518
+771,687
+189% +$974K ﹤0.01% 4114
2025
Q4 		$499K Sell
408,831
-128,506
-24% -$193K ﹤0.01% 4944
2025
Q3 		$795K Sell
537,337
-313,137
-37% -$478K ﹤0.01% 4792
2025
Q2 		$987K Buy
+850,474
New +$1.2M ﹤0.01% 4421
2024
Q4 		– Sell
-244,640
Closed -$2.74M – 6345
2024
Q3 		$2.74M Buy
244,640
+171,350
+234% +$2.14M ﹤0.01% 3405
2024
Q2 		$788K Buy
73,290
+42,751
+140% +$551K ﹤0.01% 4275
2024
Q1 		$455K Buy
+30,539
New +$504K ﹤0.01% 4881
2023
Q4 		– Sell
-181,884
Closed -$3.15M – 6433
2023
Q3 		$3.15M Sell
181,884
-175,679
-49% -$3.05M ﹤0.01% 3159
2023
Q2 		$6.48M Sell
357,563
-14,240
-4% -$337K ﹤0.01% 2416
2023
Q1 		$9.89M Buy
371,803
+165,072
+80% +$4.7M 0.01% 1969
2022
Q4 		$4M Buy
206,731
+12,849
+7% +$269K ﹤0.01% 2999
2022
Q3 		$4.05M Sell
193,882
-26,331
-12% -$504K ﹤0.01% 3106
2022
Q2 		$1.76M Buy
220,213
+162,146
+279% +$1.04M ﹤0.01% 3836
2022
Q1 		$407K Sell
58,067
-6,196
-10% -$63.2K ﹤0.01% 5279
2021
Q4 		$868K Buy
64,263
+30,867
+92% +$491K ﹤0.01% 4536
2021
Q3 		$564K Buy
33,396
+16,077
+93% +$341K ﹤0.01% 5238
2021
Q2 		$504K Sell
17,319
-46,047
-73% -$1.43M ﹤0.01% 5304
2021
Q1 		$2.49M Buy
63,366
+31,570
+99% +$1.03M ﹤0.01% 3319
2020
Q4 		$722K Buy
31,796
+14,648
+85% +$367K ﹤0.01% 3946
2020
Q3 		$388 Sell
17,148
-52,920
-76% -$1.32M ﹤0.01% 3704
2020
Q2 		$2.27M Buy
+70,068
New +$1.86M ﹤0.01% 2429

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Israel Englander's PLRX Position: Q2 2026 in Review

Israel Englander reduced its Pliant Therapeutics (PLRX) stake by 53% in Q2 2026, selling an estimated $756K and leaving 559,447 shares worth $638K. The position accounts for ﹤0.01% of the portfolio, ranked #4610.

Israel Englander first reported a position in PLRX in Q2 2020 and has held it in 22 quarters since. The position peaked at $9.89M in Q1 2023. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

  • Israel Englander held 559,447 shares of Pliant Therapeutics worth $638K as of Q2 2026.
  • Israel Englander sold 621,071 Pliant Therapeutics shares in Q2 2026, an estimated $756K.
  • Pliant Therapeutics made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4610 holding.
  • Israel Englander first reported a position in Pliant Therapeutics in Q2 2020 and has held it in 22 quarters since.
  • Israel Englander's Pliant Therapeutics position peaked at $9.89M in Q1 2023.
  • 86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.